After hours: March 21 at 7:19:28 PM EDT Loading Chart for MDGL ...

Madrigal reported better-than-expected Q4 results. The company also announced positive new two-year data from a phase 3 study of its MASH drug Rezdiffra. Madrigal reported fourth-quarter revenue ...

PORT ST. LUCIE, Fla. -- The Mets’ bench competition experienced some early upheaval on Sunday, when infielder Nick Madrigal dislocated his left shoulder. Manager Carlos Mendoza announced on Monday ...

Dandadan chapter 183 opens up with Ken “Okarun” Takakura, Aira Shiratori, and Kinta Sakata arriving at their school. Kinta reveals that the video transmission from Kouki Yukisiro’s hair ...

Nick Madrigal dislocated his left shoulder during today’s Spring Training split-squad game between the Mets and Nationals. In the first inning of the game, Madrigal (who was playing shortstop ...

RICHARDSON, Texas and SARATOGA, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Mavenir, the cloud-native network infrastructure provider building the future of networks, and Aira Technologies, a pioneer in ...

Shares of Madrigal Pharmaceuticals (NASDAQ: MDGL) were soaring 15.2% higher as of 11:05 a.m. ET on Wednesday. The big gain came after the small biopharmaceutical company announced its fourth ...

Madrigal (shoulder) was placed on the 60-day injured list Monday. It was reported earlier in the day that Madrigal is expected to miss a significant period of time recovering from a fractured left ...

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. The company ...

Madrigal Pharmaceuticals, Inc.'s Rezdiffra, the first approved drug for MASH, showed strong sales growth, with Q4 net sales up 66% to $103.3m. Despite a net loss of $466m in 2024, Madrigal's cash ...